These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32964984)

  • 1. LncRNA FOXC2-AS1 stimulates proliferation of melanoma via silencing p15 by recruiting EZH2.
    Xu DF; Tao XH; Yu Y; Teng Y; Huang YM; Ma JW; Fan YB
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8940-8946. PubMed ID: 32964984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2.
    Chen Y; Gu M; Liu C; Wan X; Shi Q; Chen Q; Wang Z
    Gene; 2019 Feb; 686():37-42. PubMed ID: 30389560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of ZEB2-AS1 inhibits cell proliferation, invasion and induces apoptosis in osteosarcoma by combining with EZH2.
    Zhang B; Fan DB; Liu L; Qin Y; Feng DQ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6533-6539. PubMed ID: 32633340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.
    Ou M; Li X; Zhao S; Cui S; Tu J
    EBioMedicine; 2020 May; 55():102694. PubMed ID: 32335370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
    Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.
    Chen RY; Ju Q; Feng LM; Yuan Q; Zhang L
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8371-8376. PubMed ID: 31646567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FOXC2 antisense transcript accelerates non-small-cell lung cancer tumorigenesis via silencing p15.
    Sun Z; He C; Xiao M; Wei B; Zhu Y; Zhang G; Zhou H; Yuan J; Hu X; Yi Y
    Am J Transl Res; 2019; 11(7):4552-4560. PubMed ID: 31396359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.
    Zhang G; Xu Y; Wang S; Gong Z; Zou C; Zhang H; Ma G; Zhang W; Jiang P
    J Cell Physiol; 2019 Apr; 234(4):5163-5174. PubMed ID: 30256413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma.
    Chen L; Ma D; Li Y; Li X; Zhao L; Zhang J; Song Y
    Int J Mol Med; 2018 Mar; 41(3):1275-1282. PubMed ID: 29286144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FOXD2-AS1 stimulates glioma progression through inhibiting P53.
    Zhao QS; Ying JB; Jing JJ; Wang SS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4382-4388. PubMed ID: 32373975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell Lung Carcinoma via Suppressing PTEN Level.
    Chen X; Wang K
    Med Sci Monit; 2019 Nov; 25():8363-8370. PubMed ID: 31695021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
    Meng XF; Zhao LY; Chu XF
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53.
    Wei LJ; Bai DM; Wang ZY; Liu BC
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):130-136. PubMed ID: 31957825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of ZEB2-AS1 inhibits cell invasion and induces apoptosis in colorectal cancer.
    Wu X; Zhu H; Xie Y; Gu X; Zhang L; Huang L
    J BUON; 2020; 25(1):194-201. PubMed ID: 32277632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
    Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
    Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
    Chen X; Gao J; Yu Y; Zhao Z; Pan Y
    Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2.
    Bai Y; Li S
    J Cell Biochem; 2020 Jan; 121(1):353-362. PubMed ID: 31219209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
    Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
    Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.